Copanlisib Hydrochloride

CHEMBL3545068 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
553.4 g/mol
LogP
Phase
4

A hydrochloride salt of copanlisib, a targeted therapy that blocks PI3K enzymes involved in cancer cell survival and growth. It is used to treat certain types of lymphoma that have not responded to other treatments.

Berat Molekul

553,4000 g/mol

TPSA

140,00 Ų

Area Terapeutik

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21.Cl.Cl

InChI

InChI=1S/C23H28N8O4.2ClH/c1-33-19-17(35-10-2-6-30-8-11-34-12-9-30)4-3-16-18(19)28-23(31-7-5-25-20(16)31)29-21(32)15-13-26-22(24)27-14-15;;/h3-4,13-14H,2,5-12H2,1H3,(H2,24,26,27)(H,28,29,32);2*1H

Molecular Formula

C23H30Cl2N8O4

HBD / HBA

4 / 9

Ikatan yang Dapat Dirotasi

7

Atom Berat

37

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A hydrochloride salt of copanlisib, a targeted therapy that blocks PI3K enzymes involved in cancer cell survival and growth. It is used to treat certain types of lymphoma that have not responded to other treatments.

Yes, Copanlisib Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3545068. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 135565785. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.